1. Home
  2. NTHI vs SGC Comparison

NTHI vs SGC Comparison

Compare NTHI & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • SGC
  • Stock Information
  • Founded
  • NTHI 2008
  • SGC 1920
  • Country
  • NTHI United States
  • SGC United States
  • Employees
  • NTHI N/A
  • SGC N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • SGC Apparel
  • Sector
  • NTHI Health Care
  • SGC Consumer Discretionary
  • Exchange
  • NTHI Nasdaq
  • SGC Nasdaq
  • Market Cap
  • NTHI 211.9M
  • SGC 215.7M
  • IPO Year
  • NTHI N/A
  • SGC N/A
  • Fundamental
  • Price
  • NTHI $10.10
  • SGC $9.20
  • Analyst Decision
  • NTHI
  • SGC Strong Buy
  • Analyst Count
  • NTHI 0
  • SGC 3
  • Target Price
  • NTHI N/A
  • SGC $17.33
  • AVG Volume (30 Days)
  • NTHI 42.8K
  • SGC 30.8K
  • Earning Date
  • NTHI 11-19-2025
  • SGC 11-03-2025
  • Dividend Yield
  • NTHI N/A
  • SGC 5.79%
  • EPS Growth
  • NTHI N/A
  • SGC N/A
  • EPS
  • NTHI N/A
  • SGC 0.52
  • Revenue
  • NTHI $59,990.00
  • SGC $576,240,000.00
  • Revenue This Year
  • NTHI N/A
  • SGC $1.63
  • Revenue Next Year
  • NTHI N/A
  • SGC $3.28
  • P/E Ratio
  • NTHI N/A
  • SGC $18.32
  • Revenue Growth
  • NTHI N/A
  • SGC 4.03
  • 52 Week Low
  • NTHI $3.20
  • SGC $9.11
  • 52 Week High
  • NTHI $25.00
  • SGC $18.48
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • SGC 30.82
  • Support Level
  • NTHI N/A
  • SGC $9.76
  • Resistance Level
  • NTHI N/A
  • SGC $10.23
  • Average True Range (ATR)
  • NTHI 0.00
  • SGC 0.41
  • MACD
  • NTHI 0.00
  • SGC -0.01
  • Stochastic Oscillator
  • NTHI 0.00
  • SGC 10.37

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.

Share on Social Networks: